A systematic review on effect of sodium-glucose cotransporter-2 inhibitors on the metabolic and endocrinological profile of patients with polycystic ovarian syndrome

• Published in: Expert opinion on pharmacotherapy Vol. 25; no. 14; p. 1953
• Main Authors: Roy, Madhura, Parveen, Rizwana, Khan, Parvej, Majid, Haya, Pathak, Mani, Saxena, Rajesh, Nidhi
• Format: Journal Article
• Language: English
• Published: England 01.10.2024
• Subjects: Blood Glucose - drug effects; Blood Glucose - metabolism; Female; Humans; Insulin Resistance; Polycystic Ovary Syndrome - drug therapy; Polycystic Ovary Syndrome - metabolism; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2 Inhibitors - adverse effects; Sodium-Glucose Transporter 2 Inhibitors - pharmacology; Sodium-Glucose Transporter 2 Inhibitors - therapeutic use; sodium-glucose cotransporter 2 inhibitors; Polycystic ovarian syndrome; oral hypoglycaemic agents; insulin resistance; body mass index
• ISSN: 1744-7666
• DOI: 10.1080/14656566.2024.2407513

Polycystic ovarian syndrome (PCOS) has been a common metabolic and endocrinal disorder, prevalent amongst women belonging to the reproductive age group. The aim of this systematic review was to assess the safety and efficacy profile of sodium-glucose cotransporter 2 (SGLT2) inhibitors (Canagliflozin...